secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001628280-23-032140
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics faces Nasdaq delisting over low stock price; cash $6.7M
--------------------------------------------------------------------------

- Nasdaq notified Avalo of delisting due to bid price ≤ $0.10 for 10 consecutive days (Low Priced Stock Rule).
- Company to request hearing by Sept 19; considering reverse stock split to regain compliance.
- Preliminary cash and equivalents of ~$6.7M as of Sept 12, 2023.
- Raised ~$12.9M net from at-the-market offering (50.8M shares) through Sept 8; additional $1.8M from 16.1M shares after Sept 8.
- Shares outstanding: 62,870,563 as of Sept 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/0001628280-23-032140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/avtx-20230912.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-032140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer